Becton, Dickinson and Company
Becton, Dickinson and Company committed to continuing to work with Direct Relief, a leading nonprofit organization, to provide $100,000 of financial support.
BD also committed to providing in-kind donations of insulin injection devices for distribution to countries serving refugee populations. In addition, Direct Relief committed to engaging with the U.S. government to advocate for other collaborative initiatives for humanitarian support for Syrian refugees to help control non-communicable diseases (NCDs) such as diabetes among refugee populations. Refugees are particularly vulnerable to health problems associated with NCDs due to their limited access to health services.